Used primarily in pharmaceutical research as a key intermediate in the synthesis of targeted protein degraders, particularly cereblon E3 ligase modulators. Its bromomethyl functional group allows for efficient conjugation to other molecules, enabling the development of PROTACs (proteolysis-targeting chimeras) that direct specific proteins for degradation. This compound is valuable in oncology and immunology drug discovery due to its role in enhancing selectivity and potency of therapeutic agents. It is also employed in the preparation of analogs for structure-activity relationship studies.